Study: Okokon 2015, Cochrane Database of Systematic Reviews
Topical antifungals for seborrhoeic dermatitis
Citation
Okokon EO, Verbeek JH et al (2015). Cochrane Database of Systematic Reviews. PubMed id 25933684.
Cards that cite this study (1)
Each card gives its own wording for who was tested, how and what was found.
- Dry, itchy, flaky scalp and dandruff Tier B moderate
B Adolescents and adults with seborrhoeic dermatitis of the face or scalp, randomised trials in mixed populations (n=not stated)
Cochrane systematic review and meta-analysis.
Topical ketoconazole 2% gave a 31% lower risk of failed clearance than placebo at four weeks (risk ratio 0.69, 95% CI 0.59-0.81, low-quality evidence), a remission rate similar to steroids with fewer side effects, and results similar to ciclopirox. The authors note that 24 trials appeared to have conflicts of interest such as pharmaceutical funding.
As recorded in this card: Okokon EO, Verbeek JH et al (2015), Cochrane Database of Systematic Reviews, [review]
Note: Trials were not selected for afro hair or dark skin.
This is information, not medical advice. If you are worried, see a doctor or pharmacist. How we grade the evidence. All studies.